Cargando…

Establishment of a novel survival assessment and prediction model for advanced gastric cancer patients receiving immunotherapy

Currently, there are only a few risk assessment tools that provide predictions of survival duration for patients with gastric cancer (GC) receiving immunotherapy. The purpose of the present study was to develop and validate a nomogram that uses statistical data to predict survival and make risk asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Mingmin, Yang, Yang, Zhao, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502925/ https://www.ncbi.nlm.nih.gov/pubmed/37720671 http://dx.doi.org/10.3892/ol.2023.14038

Ejemplares similares

Blood alkaline phosphatase predicts prognosis of patients with advanced HER2-negative gastric cancer receiving immunotherapy
por: Hu, Jianli, et al.
Publicado: (2021)

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy
por: Gou, Miaomiao, et al.
Publicado: (2022)

Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy
por: Wang, Chao-Yang, et al.
Publicado: (2020)

Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy
por: Li, Qian, et al.
Publicado: (2023)

Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy
por: Bolte, Fabian J., et al.
Publicado: (2022)

Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy
por: Fan, Xiaona, et al.
Publicado: (2021)

Establishment and verification of prediction model of occult peritoneal metastasis in advanced gastric cancer
por: Gao, Hengfei, et al.
Publicado: (2023)

Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response
por: Chen, Yan, et al.
Publicado: (2022)

Necroptosis‐related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer
por: Chen, Fangyue, et al.
Publicado: (2022)

Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
por: Feng, Ying, et al.
Publicado: (2022)

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
por: Kim, Jinchul, et al.
Publicado: (2020)

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study
por: Huang, Jian, et al.
Publicado: (2023)

Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
por: Li, Meihui, et al.
Publicado: (2021)

Establishment of Decision Rules and Risk Assessment Model for Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer
por: Huang, Chao, et al.
Publicado: (2020)

Early Increase in Circulating PD-1(+)CD8(+) T Cells Predicts Favorable Survival in Patients with Advanced Gastric Cancer Receiving Chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2023)

Characterization of Platelet Function-Related Gene Predicting Survival and Immunotherapy Efficacy in Gastric Cancer
por: Xia, Yan, et al.
Publicado: (2022)

Establishment and validation of novel MRI radiomic feature-based prognostic models to predict progression-free survival in locally advanced rectal cancer
por: Xie, Fei, et al.
Publicado: (2022)

LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
por: Xu, Wei, et al.
Publicado: (2021)

Development and validation of a novel T cell proliferation-related prognostic model for predicting survival and immunotherapy benefits in melanoma
por: Chen, Jiajie, et al.
Publicado: (2023)

A Novel Hematological Inflammation-Nutrition Score (HINS) and Its Related Nomogram Model to Predict Survival Outcome in Advanced Gastric Cancer Patients Receiving First-Line Palliative Chemotherapy
por: Chen, Chen, et al.
Publicado: (2023)

The amputation and survival of patients with diabetic foot based on establishment of prediction model
por: Lin, Chujia, et al.
Publicado: (2020)

Postoperative intraperitoneal hyperthermic perfusion improve survival for advanced gastric cancer
por: Zhang, Hong-Wei, et al.
Publicado: (2019)

Establishment of a Novel Prognostic Prediction Model for Gastric Cancer Based on Necroptosis-Related Genes
por: Zhu, Zhong-zhong, et al.
Publicado: (2022)

Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy
por: Chen, Yiqun, et al.
Publicado: (2023)

Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
por: Jin, Xin, et al.
Publicado: (2022)

Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later‐line nivolumab monotherapy—The Asahikawa Gastric Cancer Cohort Study (AGCC)
por: Tanaka, Kazuyuki, et al.
Publicado: (2021)

The Association between Blood Indexes and Immune Cell Concentrations in the Primary Tumor Microenvironment Predicting Survival of Immunotherapy in Gastric Cancer
por: Yuan, Jiajia, et al.
Publicado: (2022)

Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy
por: Yang, Liu-Ting, et al.
Publicado: (2021)

Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma
por: Li, Jianyi, et al.
Publicado: (2021)

Identification of a six-gene signature to predict survival and immunotherapy effectiveness of gastric cancer
por: Wang, Qi, et al.
Publicado: (2023)

Establishment of a Risk Prediction Model for Pulmonary Infection in Patients with Advanced Cancer
por: Yang, Liangliang, et al.
Publicado: (2022)

Establishment of a Survival Risk Prediction Model for Adolescent and Adult Osteosarcoma Patients
por: Gao, Zhixiang, et al.
Publicado: (2022)

Establishment and validation of a novel nomogram for survival prediction of ovarian carcinosarcoma
por: Liu, Yi, et al.
Publicado: (2022)

Immunotherapies for advanced hepatocellular carcinoma
por: Sun, Li-Yang, et al.
Publicado: (2023)

Establishment and validation of the survival prediction risk model for appendiceal cancer
por: Liu, Tao, et al.
Publicado: (2022)

The Relationship Between ZEB1-AS1 Expression and the Prognosis of Patients With Advanced Gastric Cancer Receiving Chemotherapy
por: Chai, Haina, et al.
Publicado: (2019)

Assessment of sarcopenia as a predictor of poor overall survival for advanced non-small-cell lung cancer patients receiving salvage anti-PD-1 immunotherapy
por: Wang, Yixing, et al.
Publicado: (2021)

The Predictive Model Construction for Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy
por: Gao, Weitong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h1k90odn9u8hunhma1q2p6tll8